Page last updated: 2024-09-04

docetaxel anhydrous and Malignant Mesothelioma

docetaxel anhydrous has been researched along with Malignant Mesothelioma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chang, H; Du, XM; Gao, Y; Li, Y; Li, Z; Wei, YP; Zhang, JM	1

Other Studies

1 other study(ies) available for docetaxel anhydrous and Malignant Mesothelioma

Article	Year
Clinicopathological characteristics of primary peritoneal epithelioid mesothelioma of clear cell type: A case report. Medicine, 2021, Mar-26, Volume: 100, Issue:12 Topics: Aged; Antineoplastic Agents; Cisplatin; Cytoreduction Surgical Procedures; Docetaxel; Embolization, Therapeutic; Exome Sequencing; Humans; Hyperthermic Intraperitoneal Chemotherapy; Immunohistochemistry; Male; Mesothelioma, Malignant; Pemetrexed; Peritoneal Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Von Hippel-Lindau Tumor Suppressor Protein	2021

Article

Year

Clinicopathological characteristics of primary peritoneal epithelioid mesothelioma of clear cell type: A case report.

Medicine, 2021, Mar-26, Volume: 100, Issue:12

Topics: Aged; Antineoplastic Agents; Cisplatin; Cytoreduction Surgical Procedures; Docetaxel; Embolization, Therapeutic; Exome Sequencing; Humans; Hyperthermic Intraperitoneal Chemotherapy; Immunohistochemistry; Male; Mesothelioma, Malignant; Pemetrexed; Peritoneal Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Von Hippel-Lindau Tumor Suppressor Protein

2021